Is imaging the future of axillary staging in breast cancer?

Muneer Ahmed, Sasha I Usiskin, Margaret A Hall-Craggs, Michael Douek

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

Axillary management in patients with breast cancer has become much less invasive with the introduction of sentinel lymph node biopsy (SLNB). However, over 70 % of SLNBs are negative, questioning the generic use of this invasive procedure. Emerging evidence indicates that breast cancer patients with a low axillary burden of disease do not benefit from axillary lymph node dissection (ALND). Non-invasive techniques such as paramagnetic iron oxide contrast-enhanced magnetic resonance imaging (MRI) may provide genuine alternatives to axillary staging and should be evaluated within clinical trials. Selective axillary surgery could then be offered based on imaging findings and for therapeutic intent. This non-operative approach would reduce morbidity further and facilitate interpretation of follow-up imaging.
Original languageEnglish
Article numberN/A
Pages (from-to)288-293
Number of pages6
JournalEuropean Radiology
Volume24
Issue number2
DOIs
Publication statusPublished - Feb 2014

Fingerprint

Dive into the research topics of 'Is imaging the future of axillary staging in breast cancer?'. Together they form a unique fingerprint.

Cite this